Bahrain Celebrates Eye Surgical Breakthrough

TDT | Manama

Email : editor@newsofbahrain.com

A cutting-edge eye surgery has opened a new chapter in Bahrain’s medical history, with the successful implantation of the country’s first Preserflo MicroShunt, a device transforming the treatment of glaucoma.

The milestone procedure was performed by Dr. Ahmed AlMeer, a Bahraini eye surgeon who recently returned from Canada after completing advanced training.

Conducted at Dr. Haifa Eye Hospital, the surgery marks Bahrain’s entry into a global shift towards safer and less invasive glaucoma treatments.

Dr. AlMeer said he felt confident as he held the tiny Preserflo device in his hands, aware of the significance of the moment.

“I had already performed this surgery many times abroad, so I felt well-prepared. What I felt more than pressure was a deep sense of responsibility,” he said.

Glaucoma, a chronic eye disease that can lead to irreversible blindness, is traditionally treated with trabeculectomy, a procedure that involves creating a larger drainage opening in the eye.

This method often results in longer recovery times and increased risk of complications.

The Preserflo MicroShunt, however, is a minimally invasive glaucoma surgery (MIGS) device just 8.5 mm in length.

It creates a controlled outflow for fluid, reducing intraocular pressure with minimal disruption to the eye’s anatomy.

According to Dr. AlMeer, this translates to quicker healing, fewer complications, and better comfort for patients.